SGLT2 inhibitors and cirrhosis: A unique perspective on the comanagement of diabetes mellitus and ascites
Saad Saffo, Tamar Taddei – 26 July 2018
Patient 1 with decompensated nonalcoholic steatohepatitis cirrhosis with inability to lose weight should undergo transplantation
Yuval A. Patel, Kara Wegermann, Carl L. Berg, Lindsay Y. King – 26 July 2018
Patient 1 with decompensated nonalcoholic steatohepatitis cirrhosis with inability to lose weight should undergo transplantation
Yuval A. Patel, Kara Wegermann, Carl L. Berg, Lindsay Y. King – 26 July 2018
SGLT2 inhibitors and cirrhosis: A unique perspective on the comanagement of diabetes mellitus and ascites
Saad Saffo, Tamar Taddei – 26 July 2018
Pain management in patients with cirrhosis
Mina Rakoski, Preeya Goyal, Michelle Spencer‐Safier, Jill Weissman, Gina Mohr, Michael Volk – 26 July 2018
Liver Metastases From Gastric Adenocarcinoma Mimicking Multinodular Hepatocellular Carcinoma
Álvaro Díaz‐González, Ester Monclús, Anna Darnell, Manel Solé, Jordi Bruix – 25 July 2018
Liver Metastases From Gastric Adenocarcinoma Mimicking Multinodular Hepatocellular Carcinoma
Álvaro Díaz‐González, Ester Monclús, Anna Darnell, Manel Solé, Jordi Bruix – 25 July 2018
Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease
Cristina Margini, Giuseppe Murgia, Guido Stirnimann, Andrea De Gottardi, Nasser Semmo, Stefania Casu, Jaime Bosch, Jean‐François Dufour, Annalisa Berzigotti – 24 July 2018 – Obesity and steatosis have been associated with liver disease progression in patients with compensated advanced chronic liver disease (cACLD) (liver stiffness measurement [LSM] ≥ 10 kPa). The controlled attenuation parameter (CAP) estimates steatosis during LSM by transient elastography. We aimed to evaluate whether CAP is associated with the development of clinically relevant events in cACLD.
The Reactive Oxygen Species–Mitophagy Signaling Pathway Regulates Liver Endothelial Cell Survival During Ischemia/Reperfusion Injury
Ricky H. Bhogal, Christopher J. Weston, Susanne Velduis, Henri G. D. Leuvenink, Gary M. Reynolds, Scott Davies, Luu Nyguet‐Thin, Mohammed Alfaifi, Emma L. Shepard, Yuri Boteon, Lorraine Wallace, Ye H. Oo, David H. Adams, Darius F. Mirza, Hynek Mergental, Gillian Muirhead, Barnaby T. F. Stephenson, Simon C. Afford – 24 July 2018 – Ischemia/reperfusion injury (IRI) is the main cause of complications following liver transplantation. Reactive oxygen species (ROS) were thought to be the main regulators of IRI.